Agenus, Inc.
(NASDAQ : AGEN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
-0.39%170.631.3%$493.25m
BIIBBiogen Inc.
-1.87%230.641.3%$471.37m
CELGCelgene Corporation
-0.38%95.991.3%$455.47m
GILDGilead Sciences, Inc.
-0.11%66.430.9%$434.26m
ILMNIllumina, Inc.
-0.90%310.023.5%$314.84m
REGNRegeneron Pharmaceuticals, Inc.
-2.20%313.062.6%$292.06m
AAgilent Technologies, Inc.
-2.21%66.471.6%$203.07m
VRTXVertex Pharmaceuticals Incorporated
-1.03%170.591.9%$179.30m
EXASExact Sciences Corporation
-2.32%92.7125.3%$159.87m
ALXNAlexion Pharmaceuticals, Inc.
-1.60%125.522.0%$147.26m
BMRNBioMarin Pharmaceutical Inc.
-0.53%87.234.3%$117.93m
SRPTSarepta Therapeutics, Inc.
-1.90%119.3114.7%$110.01m
INCYIncyte Corporation
-0.49%78.642.5%$105.21m
IONSIonis Pharmaceuticals, Inc.
-2.00%67.198.2%$96.76m
ALNYAlnylam Pharmaceuticals, Inc
-2.81%65.919.2%$92.28m

Company Profile

Agenus, Inc. is a clinical-stage immuno-oncology company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes AGEN1884, AGEN2034, INCAGN1876, INCAGN1949, Prophage, AutoSynVax, PhosphoSynVax, and AS-21 Stimulon. The company was founded by Garo H. Armen and Pramod K. Srivastava in March 1994 and is headquartered in Lexington, MA.